Vident Investment Advisory, LLC - CARDIOL THERAPEUTICS INC ownership

CARDIOL THERAPEUTICS INC's ticker is CRTPF and the CUSIP is 14161Y200. A total of 34 filers reported holding CARDIOL THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Vident Investment Advisory, LLC ownership history of CARDIOL THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$74,761
-49.8%
146,807
+0.9%
0.00%
-40.0%
Q3 2022$149,000
-16.3%
145,432
+7.1%
0.01%0.0%
Q2 2022$178,000
-8.7%
135,853
+7.7%
0.01%0.0%
Q1 2022$195,000
+101.0%
126,157
+139.6%
0.01%
+66.7%
Q4 2021$97,000
-53.4%
52,645
+4.1%
0.00%
-50.0%
Q3 2021$208,00050,5660.01%
Other shareholders
CARDIOL THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
MMCAP International Inc. SPC 3,353,400$3,454,0000.27%
Marble Harbor Investment Counsel, LLC 36,900$38,0000.01%
Vident Investment Advisory, LLC 145,432$149,0000.01%
Private Ocean, LLC 20,651$21,0000.00%
Robertson Stephens Wealth Management, LLC 27,855$28,0000.00%
Mirae Asset Global Investments Co., Ltd. 870,562$893,0000.00%
Caption Management, LLC 99,900$102,0000.00%
Rise Advisors, LLC 1,000$1,0000.00%
OLIVER LAGORE VANVALIN INVESTMENT GROUP 500$1,0000.00%
VALLEY NATIONAL ADVISERS INC 5,000$3,0000.00%
View complete list of CARDIOL THERAPEUTICS INC shareholders